Plain language summary of the BICSTaR study: one-year results of bictegravir, emtricitabine, and tenofovir alafenamide for HIV treatment

This Plain Language Summary of publication article (PLSP) from Future Microbiology discusses the ongoing BICSTaR study, which evaluates the effectiveness and safety of the HIV treatment bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). B/F/TAF is a single tablet combining three drugs that work together to lower HIV levels until the virus becomes undetectable in the blood.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts’ and was published in HIV Medicine.

Visit Wiley using the link to read the original article.

• antiretroviral therapy
• HIV medicine
• lay language summary
• plain language summary
• real-world data
• treatment naive
• treatment-experienced